Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.97 - $3.08 $12,563 - $39,892
-12,952 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.55 - $5.23 $7,976 - $16,359
-3,128 Reduced 19.45%
12,952 $38,000
Q3 2021

Nov 15, 2021

SELL
$6.07 - $9.89 $153,170 - $249,564
-25,234 Reduced 61.08%
16,080 $117,000
Q2 2021

Aug 16, 2021

BUY
$9.76 - $14.15 $97,463 - $141,301
9,986 Added 31.88%
41,314 $404,000
Q3 2020

Nov 17, 2020

BUY
$6.52 - $8.94 $37,737 - $51,744
5,788 Added 22.66%
31,328 $213,000
Q2 2020

Aug 17, 2020

SELL
$6.18 - $10.76 $29,565 - $51,475
-4,784 Reduced 15.78%
25,540 $192,000
Q1 2020

May 13, 2020

BUY
$6.03 - $15.24 $2,062 - $5,212
342 Added 1.14%
30,324 $190,000
Q2 2019

Aug 14, 2019

BUY
$13.4 - $17.67 $102,603 - $135,299
7,657 Added 34.3%
29,982 $442,000
Q1 2019

May 09, 2019

BUY
$5.7 - $19.7 $92,471 - $319,593
16,223 Added 265.86%
22,325 $368,000
Q3 2018

Nov 14, 2018

BUY
$11.32 - $15.7 $69,074 - $95,801
6,102 New
6,102 $73,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.